Last updated: April 11, 2023
Sponsor: Sint Maartenskliniek
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05827380
NL80178.091.21 / 0996
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- > 6 months after first unilateral supratentorial stroke (chronic phase)
- Able to walk at least 10 minutes independently
Exclusion
Exclusion Criteria:
- Any other neurological or musculoskeletal disease affecting gait or balance (e.g.Parkinson's disease, knee osteoarthritis)
- Contractures or spasticity requiring other treatment (e.g. botulinum toxin treatment)within the duration of the training period.
- Has received multiple training sessions on C-Mill or GRAIL in the past 12 months
- Severe cognitive or visuo-spatial impairments limiting comprehension of instructionsor correct perception of the environments
Study Design
Total Participants: 84
Study Start date:
September 22, 2022
Estimated Completion Date:
December 31, 2024
Connect with a study center
Sint Maartenskliniek
Ubbergen, 6574NA
NetherlandsActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.